Contamination, Hormones, In-Vitro and Protein

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Contamination

Hormones

In-Vitro

Protein

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

NOVEMBER 29, 2021

Recombinant therapeutic proteins. Fusion proteins. They may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.

Development

Development Protein Production Hormones

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

MAY 4, 2021

Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Billion and Adjusted Diluted EPS (2) to a Range of $3.55 Now Anticipates Revenues of Approximately $26 Billion for BNT162b2, Reflecting 1.6 Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-April 2021. per share amounts). Reported Diluted EPS (1).

Vaccination

Vaccination Vaccine Production Sales

Clinical Research Informer

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

Stay Connected